Cargando…
Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis
Contrast-induced nephropathy (CIN) has become the third-leading cause of hospital-acquired acute renal injury. Although alprostadil has been proposed as an effective preventative measure, this conclusion remains inconsistent. Thus, we performed a meta-analysis of the published studies on this topic...
Autores principales: | Zhang, Jing-Zhan, Kang, Xiao-Jing, Gao, Ying, Zheng, Ying-Ying, Wu, Ting-Ting, Li, Long, Liu, Fen, Yang, Yi-Ning, Li, Xiao-Mei, Ma, Yi-Tong, Xie, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430773/ https://www.ncbi.nlm.nih.gov/pubmed/28432310 http://dx.doi.org/10.1038/s41598-017-01160-1 |
Ejemplares similares
-
Author Correction: Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis
por: Zhang, Jing-Zhan, et al.
Publicado: (2019) -
Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients
por: XU, RONG-HE, et al.
Publicado: (2013) -
The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis
por: Ye, Ziliang, et al.
Publicado: (2016) -
Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate
por: Qin, Lili, et al.
Publicado: (2017) -
Clinical Efficacy of Alprostadil Combined with α-lipoic Acid in the Treatment of Elderly Patients with Diabetic Nephropathy
por: Hong, Yan, et al.
Publicado: (2017)